Stock Earnings
Palisade Bio Inc’s latest rating changes from various analysts
In a filing, Palisade Bio Inc revealed its CEO, CFO, Director Finley John David acquired Company’s shares for reported $4692.0
Menu
In a filing, Palisade Bio Inc revealed its CEO, CFO, Director Finley John David acquired Company’s shares for reported $4692.0
Palisade Bio Inc’s filing revealed that its CEO, CFO, Director Finley John David acquired Company’s shares for reported $4692.0 on
In a filing, Palisade Bio Inc revealed its CEO, CFO, Director Finley John David acquired Company’s shares for reported $4692.0
Palisade Bio Inc. (NASDAQ:PALI) does about 3.63M shares in volume on a normal day but saw 277025 shares change hands